Skip to main content
S 4016 109th Congress Senate Health Administrative remedies Civil actions and liability Commerce Congressional reporting requirements Department of Health and Human Services Drug approvals Drug industry Food and Drug Administration (FDA) Government Operations and Politics Injunctions Intellectual property Judicial opinions Judicial review Labeling Law Licenses Patent infringement Patents Product safety

Access to Life-Saving Medicine Act

Introduced: September 29, 2006 Introduced by: Schumer, Charles E. Democratic · New York See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 29, 2006
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 29, 2006
Introduced in Senate
 Plain-English summary Congressional Research Service

Access to Life-Saving Medicine Act - Amends the Public Health Service Act to establish a process for the approval of a comparable biological product based on its similarity to a previously licensed biological product (the reference product). Allows a person to file an abbreviated comparable product application with the Secretary of Health and Human Services that includes: (1) data demonstrating that the product is comparable to the reference product; (2) information to show that the conditions or conditions of use prescribed, recommended, or suggested in the labeling proposed for the comparable product have been previously approved for the reference product; and (3) information to show that the route of administration, the dosage form, and the strength of the comparable product are the same as those of the reference product.

Sets forth conditions for approval of such an application by the Secretary.

Allows an applicant to request that the Secretary make a determination as to the interchangeability of a comparable product and the reference product. Provides market exclusivity to such an interchangeable product.

Requires the Secretary to establish requirements for the efficient review, approval, suspension, and revocation of comparable biological product applications.

Sets forth provisions governing patent infringement claims against the license holder of a comparable product.

What's happening now September 29, 2006

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1